Westlake, CA, United States of America

Cynvenio Biosystems, Inc.


USPTO Granted Patents = 4

% Expired Patents = 75.0


Trademarks = 2

Forward Citations = 25

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Behrad Vahidi (2 out of 4 patents)

silverMedal William M Strauss (2 out of 4 patents)

bronzeMedal Robert Justice Shartle (1 out of 32 patents)

4.  Hyongsok Tom Soh (1 out of 8 patents)

5.  Bernard Strong (1 out of 21 patents)

6.  Samuel Ferguson (1 out of 1 patent)

7.  Paul Pagano (1 out of 1 patent)

8.  Jiangrong Karen Qian (1 out of 1 patent)

9.  Paul W Dempsey (1 out of 1 patent)

10.  Andre′ De Fusco (1 out of 1 patent)

11.  Yanting Zhang (1 out of 3 patents)

12.  Nancy E Stagliano (41 patents)

13.  Brian Scott Ferguson (7 patents)

14.  Andre De Fusco (0 patent)

15.  Karen Qian (0 patent)


4 patents:

Company Overview
Cynvenio Biosystems, Inc. is a leading developer of rare cell isolation and characterization technologies for critical cancer diagnostics. Their liquid biopsy solutions offer physicians and patients accurate and non-invasive tools to detect and monitor cancer. With a focus on precision medicine, Cynvenio is dedicated to improving patient outcomes through advanced molecular testing.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#2 in Westlake, CA

#14,058 in California

#60,671 in US

Westlake, CA (US)
Westlake, CA, United States of America
Forward Citations = 25

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cynvenio Biosystems, Inc.. Retrieved from https://idiyas.com/company/cynvenio-biosystems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…